These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 14571187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    von Reyn CF, Lahey T, Arbeit RD, Landry B, Kailani L, Adams LV, Haynes BC, Mackenzie T, Wieland-Alter W, Connor RI, Tvaroha S, Hokey DA, Ginsberg AM, Waddell R.
    PLoS One; 2017; 12(5):e0175215. PubMed ID: 28498853
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
    Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, Mtei L, Vuola JM, Pallangyo K, von Reyn CF.
    Vaccine; 2010 Nov 10; 28(48):7652-8. PubMed ID: 20875492
    [Abstract] [Full Text] [Related]

  • 7. Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.
    Lahey T, Matee M, Mtei L, Bakari M, Pallangyo K, von Reyn CF.
    BMC Infect Dis; 2009 Feb 23; 9():21. PubMed ID: 19236695
    [Abstract] [Full Text] [Related]

  • 8. Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
    Lahey T, Sheth S, Matee M, Arbeit R, Horsburgh CR, Mtei L, Mackenzie T, Bakari M, Vuola JM, Pallangyo K, von Reyn CF.
    J Infect Dis; 2010 Oct 15; 202(8):1265-72. PubMed ID: 20812851
    [Abstract] [Full Text] [Related]

  • 9. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ, Snowden MA, Hokey D, Dheenadhayalan V, McClain JB, Douoguih M, Pau MG, Sadoff J, Landry B.
    Vaccine; 2015 Apr 08; 33(15):1890-6. PubMed ID: 25698492
    [Abstract] [Full Text] [Related]

  • 10. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M, MVA029 Study Team.
    Clin Infect Dis; 2018 Feb 01; 66(4):554-563. PubMed ID: 29028973
    [Abstract] [Full Text] [Related]

  • 11. Preventive effects of Mycobacterium vaccae on HIV-associated tuberculosis: a systematic review.
    Chen Q, Yang X, Li Y, He X, Ma X, Ma L, Guo Z, Li L.
    J Evid Based Med; 2011 May 01; 4(2):122-9. PubMed ID: 23672702
    [Abstract] [Full Text] [Related]

  • 12. CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    Masonou T, Hokey DA, Lahey T, Halliday A, Berrocal-Almanza LC, Wieland-Alter WF, Arbeit RD, Lalvani A, von Reyn CF.
    PLoS One; 2019 May 01; 14(5):e0217091. PubMed ID: 31120957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis.
    Yang XY, Chen QF, Cui XH, Yu Y, Li YP.
    J Infect; 2010 May 01; 60(5):320-30. PubMed ID: 20156481
    [Abstract] [Full Text] [Related]

  • 16. Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis.
    Prados-Rosales R, Carreño LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J, Yu X, Wallstrom G, Magee DM, LaBaer J, Achkar JM, Jacobs WR, Chan J, Porcelli SA, Casadevall A.
    mBio; 2014 Sep 30; 5(5):e01921-14. PubMed ID: 25271291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.
    Kagina BM, Tameris MD, Geldenhuys H, Hatherill M, Abel B, Hussey GD, Scriba TJ, Mahomed H, Sadoff JC, Hanekom WA, 018-402 Clinical Lab study team, Mansoor N, Hughes J, de Kock M, Whatney W, Africa H, Krohn C, Veldsman A, Kany AL, Douoguih M, Pau MG, Hendriks J, McClainc B, Benko J, Snowden MA, Hokey DA.
    Vaccine; 2014 Oct 14; 32(45):5908-17. PubMed ID: 25218194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB.
    J Lab Clin Med; 1999 Sep 14; 134(3):244-52. PubMed ID: 10482309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.